https://www.selleckchem.com/pr....oducts/calpeptin.htm
The foremost side effects of anti-PD-1 therapy are immune related and pancreatitis associated with nivolumab treatment has been rarely reported. The patient was treating with subcutaneous insulin because of nivolumab induced diabetes mellitus. A patient was diagnosed metastatic renal cell carcinoma and treated with nivolumab. Diabetes mellitus and pancreatitis, which are immune-related adverse events were observed in the patient. After the diagnosis of nivolumab induced immune pancreatitis methylprednisolone 2 mg/kg per day intravenou
Like
Comment
Share
